10X Genomics

The AI engine Fit Assessment

Beta

10x Genomics develops advanced DNA sequencing technology and innovative tools for analyzing biological systems, enabling researchers to uncover complex cellular interactions and gene expression patterns in various fields, including oncology and immunology. Their product portfolio includes instruments, consumables, and software designed to enhance scientific discovery.

Blurb

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

HQ Location

Pleasanton (United States)

Founded

2012

Employees

1001 - 5000

Total funding raised

$3.90B

Funding Status

Post-IPO Equity, January 1, 2020
Subspaces
  • Genomic Data Analysis

Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.